Keyes K, Agnew-Blais J, Roberts A L, Hamilton A, De Vivo I, Ranu H, Koenen K
Department of Epidemiology, Columbia University, Mailman School of Public Health, 722 West 168th Street, New York, NY, 10032, USA.
Department of Epidemiology, Harvard University, 181 Longwood Avenue, Boston, MA, 02115, USA.
Soc Psychiatry Psychiatr Epidemiol. 2015 Dec;50(12):1893-904. doi: 10.1007/s00127-015-1087-1. Epub 2015 Jul 14.
The role of exogenous and endogenous sex hormones in the etiology of depression remains elusive, in part because sex hormone variation is often correlated with behaviors, life stage changes, and other factors that may influence depression. Estrogen receptor alpha (ESR1) and beta (ESR2) are known to regulate gene expression and estrogen response in areas of the brain associated with major depression and are unlikely to be correlated with exogenous factors that may influence depression.
We examined whether functional polymorphisms in these genes are associated with lifetime major depression and chronic major depression among a sample of women from the Nurses' Health Study II (N = 2527). DSM-IV depressive disorder symptoms were assessed by structured interview in 2007. Genotyping was performed on DNA extracted from blood using Taq-man.
Women with the AA alleles of ESR2 RS4986938 had the higher prevalence of lifetime major depression than women with other allele frequencies (36.7 % for those with AA versus 28.5 % with GA and 29.1 % with GG, p = 0.02) and chronic major depression (14.7 % for those with AA versus 9.3 % with GA and 9.1 % with GG, p = 0.01). History of post-menopausal hormone (PMH) use modified the association of ESR1 polymorphism RS2234693 with any lifetime depression; specifically, those with the TT allele had the highest risk of lifetime depression among PMH users, and the lowest risk of depression among non-PMH users (p value for interaction = 0.02). Further, carriers of the AA alleles in ESR1 polymorphism RS9340799 had increased prevalence of lifetime major depression only among lifetime PMH users (p = 0.007).
Our findings support the hypothesis that estrogen receptor polymorphisms influence risk for major depression; the role of estrogen receptors and other sex steroid-related genetic factors may provide unique insights into etiology.
外源性和内源性性激素在抑郁症病因学中的作用仍不明确,部分原因是性激素变化常与行为、生活阶段变化以及其他可能影响抑郁症的因素相关。已知雌激素受体α(ESR1)和β(ESR2)可调节与重度抑郁症相关的脑区中的基因表达和雌激素反应,且不太可能与可能影响抑郁症的外源性因素相关。
我们在护士健康研究II的女性样本(N = 2527)中检查了这些基因中的功能多态性是否与终生重度抑郁症和慢性重度抑郁症相关。2007年通过结构化访谈评估DSM-IV抑郁障碍症状。使用Taq-man对从血液中提取的DNA进行基因分型。
ESR2 RS4986938的AA等位基因女性终生重度抑郁症的患病率高于其他等位基因频率的女性(AA者为36.7%,GA者为28.5%,GG者为29.1%,p = 0.02)以及慢性重度抑郁症(AA者为14.7%,GA者为9.3%,GG者为9.1%,p = 0.01)。绝经后激素(PMH)使用史改变了ESR1多态性RS2234693与任何终生抑郁症之间的关联;具体而言,TT等位基因者在PMH使用者中终生抑郁症风险最高,而在非PMH使用者中抑郁症风险最低(交互作用p值 = 0.02)。此外,ESR1多态性RS9340799中AA等位基因携带者仅在终生PMH使用者中终生重度抑郁症患病率增加(p = 0.007)。
我们的研究结果支持雌激素受体多态性影响重度抑郁症风险的假说;雌激素受体和其他与性类固醇相关的遗传因素的作用可能为病因学提供独特见解。